Back to search

Netherlands· NL-bc94540a6fb3

Lenalidomide Biocon 5 mg harde capsules

A lenalidomide product containing lenalidomide, registered in Netherlands by Biocon Pharma Malta I Limited. The same ATC class is registered in 16 of our 19 countries.

ATC L04AX04

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedLenalidomide Biocon 5 mg harde capsul…ATCL04AX04REGISTER NO.NL-bc94540a6fb3PACKS LISTED1CHECKEDAugust 18, 2026

Where it is registered

Lenalidomide is registered in 16 of 19 countries.

Countries holding a registration under ATC L04AX04 (lenalidomide), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose

Lenalidomide · ATC L04AX04

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lenalidomide costs, country by country.

Normalised to the WHO defined daily dose (10 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Lenalidomide · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$47.45
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
LENALIDOMIDE
Manufacturer
Biocon Pharma Malta I Limited
Country
Netherlands (NL)
ATC code
L04AX04
ATC class
Lenalidomide
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
August 18, 2026

Packs & prices · 1

  • cbg_meb_id
    127881

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

397 interactions on record for lenalidomide.

Graded by severity as the source publishes them — 75 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Lenalidomide · interactions on record

397 records

  • 75 severe
  • 105 moderate
  • 1 minor
  • 216 info

Most severe, free to view

  • ErythropoietinB03XA01severe
  • Darbepoetin alfaB03XA02severe
  • PeginesatideB03XA04severe
  • C1-inhibitor, plasma derivedB06AC01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lenalidomide in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lenalidomide products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Lenalidomid +pharma, Lenalidomid Biocon
  • Belgium · Lenalidomid Grindeks, Lenalidomide Eg
  • Bulgaria · Lenalidomide Sandoz, Леналидомид Алкалоид-Инт
  • Cyprus · 7,5 Mg Stada, Lenalidomide Grindeks
  • Czechia · Lenalidomid Sandoz, Lenalidomid Stada
  • Germany · Lenabdor, Lenalidomid 123-Acurae Pharma
  • Denmark · Lenalidomid Grindeks, Lenalidomid Medical Valley
  • Estonia · Lenalidomide Auxilia, Lenalidomide Grindeks
  • Spain · Lenalidomida Aurovitas, Lenalidomida Grindeks
  • Finland · Ferulinor Stada, Lenalidomid Avansor
  • France · Lenalidomide Arrow, Lenalidomide Eg
  • United Kingdom (Northern Ireland) · Lenalidomide, Lenalidomide Amarox
  • Greece · Cortedal, Lenalidomide
  • Croatia · Lenalidomid Alkaloid-Int, Lenalidomid Grindeks
  • Hungary · Lenalidomid Teva, Lenalidomide Grindeks
  • Ireland · Lenalidomide Clonmel, Lenalidomide Grindeks
  • Iceland · Cortedal, Ferulinor
  • Italy · Kleder, Lenalidomide Aurobindo
  • Liechtenstein · Lenalidomide Accord, Lenalidomide Mylan
  • Lithuania · Lenalidomide G.L., Lenalidomide Grindeks
  • Luxembourg · Lenalidomide, Lenalidomide Eg
  • Latvia · Lenalidomide Grindeks, Lenalidomide Norameda
  • Malta · Lenalidomida Generis, Lenalidomide Generis
  • Norway · Ferulinor, Lenalidomid Medical Valley
  • Poland · Kleder, Lenalidomide Eugia
  • Portugal · Lenalidomida Biocon, Lenalidomida Generis
  • Romania · Lenalidomidă Alkaloid-Int, Lenalidomidă Grindeks
  • Sweden · Ferulinor, Lenalidomid Avansor
  • Slovenia · Lenabdor, Lenalidomid Alkaloid-Int
  • Slovakia · Lenalidomid Glenmark, Lenalidomid Grindeks

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ff3f62bc-0e1c-485d-8b64-b25775fc8aaf
GET /v1/drugs/ff3f62bc-0e1c-485d-8b64-b25775fc8aaf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h127881_smpc.pdf",
  "strength": null,
  "atc_label": "Lenalidomide",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg127881",
  "excipients": [
    "BRILJANTBLAUW FCF (E 133)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "GELATINE (E 441)",
    "LACTOSE 0-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "LENALIDOMIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h127881.pdf",
  "authorised_at": "2022/10/31",
  "procedure_number": "PT/H/2684/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "127881",
  "additional_monitoring": "N"
}

See everything about lenalidomide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.